Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications (Q40339607)
Jump to navigation
Jump to search
scientific article published on December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications |
scientific article published on December 2005 |
Statements
1 reference
Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications (English)
1 reference
Paul Richardson
1 reference
Kenneth C Anderson
1 reference
Nikhil C Munshi
1 reference
Dharminder Chauhan
1 reference
Teru Hideshima
1 reference
Klaus Podar
1 reference
Robert Schlossman
1 reference
Weihua Song
1 reference
Steven P Treon
1 reference
Laurence Catley
1 reference
Iris Breitkreutz
1 reference
Jooeun Bae
1 reference
Iqbal S Grewal
1 reference
Yu-Tzu Tai
1 reference
Xian-Feng Li
1 reference
Rory Coffey
1 reference
1 December 2005
1 reference
1 reference
65
1 reference
24
1 reference
11712-11720
1 reference
Identifiers
1 reference
1 reference